TuHURA Biosciences, Inc.(HURA)_个股概要_股票价格_最新资讯_行情走势_历史数据

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

HURA TuHURA Biosciences, Inc.

休市中 12-20 15:59:59 EST

4.48

+0.48

+12.00%

盘后4.28

-0.20-4.46%

19:54 EST

最高4.55	最低3.80	成交量129.43万
今开4.10	昨收4.00	日振幅18.75%
总市值1.88亿	流通市值3,661万	总股本4,203万
成交额576.42万	换手率15.84%	流通股本817.15万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"HURA","market":"US","secType":"STK","nameCN":"TuHURA Biosciences, Inc.","latestPrice":4.48,"timestamp":1734728399999,"preClose":4,"halted":0,"volume":1294289,"hourTrading":{"tag":"盘后","latestPrice":4.28,"preClose":4.48,"latestTime":"19:54 EST","volume":475356,"amount":2129243.55,"timestamp":1734742440185},"delay":0,"floatShares":8171500,"shares":42030226,"eps":-11.29079,"marketStatus":"休市中","marketStatusCode":7,"change":0.48,"latestTime":"12-20 15:59:59 EST","open":4.1,"high":4.55,"low":3.8,"amount":5764179.481661,"amplitude":0.1875,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-11.29079,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1734944400000},"adr":0,"adjPreClose":4,"preHourTrading":{"tag":"盘前","latestPrice":4.14,"preClose":4,"latestTime":"09:28 EST","volume":388,"amount":1624.400412,"timestamp":1734704880140},"postHourTrading":{"tag":"盘后","latestPrice":4.28,"preClose":4.48,"latestTime":"19:54 EST","volume":475356,"amount":2129243.55,"timestamp":1734742440185},"volumeRatio":4.171785687100165},"requestUrl":"/m/hq/s/HURA","defaultTab":"news","newsList":[{"id":"2483379740","title":"TuHURA 生物科学公司报告本季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2483379740","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483379740?lang=zh_cn&edition=full","pubTime":"2024-11-15 22:02","pubTimestamp":1731679354,"startTime":"0","endTime":"0","summary":"   * TuHURA Biosciences Inc   报告本季度调整后每股亏损1.37美元，高于去年同期的每股收益64.05美元。* 报告收入为零，分析师预期为零。* TuHURA Biosciences Inc 报告的本季度每股收益为亏损 1.37 美元。* TuHURA Biosciences Inc 的股价本季度下跌了 28.2%，今年迄今为止下跌了 17.5%。* 生物技术和医学研究同行的平均一致建议也是 \"买入\"。华尔街对 TuHURA Biosciences Inc 的 12 个月目标价中位数为 15.00 美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"TuHURA 生物科学公司报告本季度业绩 - 收益摘要","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","HURA"],"gpt_icon":0},{"id":"2481839884","title":"TuHURA Biosciences Inc   预计每股亏损10美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2481839884","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481839884?lang=zh_cn&edition=full","pubTime":"2024-11-08 23:49","pubTimestamp":1731080973,"startTime":"0","endTime":"0","summary":"   * TuHURA Biosciences Inc    预计将于11月11日公布截至2024年9月30日的财报(估计)。*    * LSEG分析师对TuHURA生物科学公司的平均预期是每股亏损10美分。* 分析师对该公司股票的评级为 \"买入\"。* 华尔街对 TuHURA Biosciences Inc 的 12 个月目标价中位数为 15.00 美元，高于其上次收盘价 5.27 美元。11月8日 - 本摘要于北京时间11月8日15:48由机器生成。除非另有说明，否则所有数据均以美元为单位。(如对本报告中的数据有任何疑问，请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"TuHURA Biosciences Inc   预计每股亏损10美分 - 财报前瞻","news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HURA"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.kintara.com","stockEarnings":[{"period":"1week","weight":-0.0913},{"period":"1month","weight":0.3617},{"period":"3month","weight":-0.2644},{"period":"6month","weight":-0.482},{"period":"1year","weight":-0.304},{"period":"ytd","weight":-0.2453}],"compareEarnings":[{"period":"1week","weight":-0.0221},{"period":"1month","weight":0.0006},{"period":"3month","weight":0.0397},{"period":"6month","weight":0.0851},{"period":"1year","weight":0.2499},{"period":"ytd","weight":0.243}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"TuHURA Biosciences, Inc.是一家内华达州公司，成立于2009年6月24日，名称为Berry Only，Inc。该公司是一家临床阶段的生物制药公司。Kintara致力于为医疗需求未得到满足的患者开发新型癌症疗法。Kintara公司正在开发两种晚期疗法，以降低风险，满足明确的未满足的医疗需求。这两个项目分别是VAL-083治疗胶质母细胞瘤（GBM）和REM-001治疗皮肤转移性乳腺癌（CMBC）。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.077817},{"month":2,"riseRate":0.125,"avgChangeRate":-0.104771},{"month":3,"riseRate":0.25,"avgChangeRate":-0.042889},{"month":4,"riseRate":0.25,"avgChangeRate":-0.056005},{"month":5,"riseRate":0.625,"avgChangeRate":1.37172},{"month":6,"riseRate":0.5,"avgChangeRate":-0.011708},{"month":7,"riseRate":0.375,"avgChangeRate":-0.030517},{"month":8,"riseRate":0.444444,"avgChangeRate":-0.105627},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.105678},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.132105},{"month":11,"riseRate":0.444444,"avgChangeRate":-0.051736},{"month":12,"riseRate":0.222222,"avgChangeRate":-0.169583}],"exchange":"NASDAQ","name":"TuHURA Biosciences, Inc.","nameEN":"TuHURA Biosciences, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"TuHURA Biosciences, Inc.(HURA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供TuHURA Biosciences, Inc.(HURA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"TuHURA Biosciences, Inc.,HURA,TuHURA Biosciences, Inc.股票,TuHURA Biosciences, Inc.股票老虎,TuHURA Biosciences, Inc.股票老虎国际,TuHURA Biosciences, Inc.行情,TuHURA Biosciences, Inc.股票行情,TuHURA Biosciences, Inc.股价,TuHURA Biosciences, Inc.股市,TuHURA Biosciences, Inc.股票价格,TuHURA Biosciences, Inc.股票交易,TuHURA Biosciences, Inc.股票购买,TuHURA Biosciences, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"TuHURA Biosciences, Inc.(HURA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供TuHURA Biosciences, Inc.(HURA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}

公司概况